Wikidata

(Q67125109)

English

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

clinical trial

In more languages

Statements

title
Phase 2 Study of Pemetrexed and Sorafenib for Treatment of Recurrent or Metastatic Triple Negative Breast Cancer (English)
0 references
start time
28 January 2016
0 references
end time
30 June 2021
0 references
number of participants
37
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q67125109&oldid=1858945841"